Suven Pharmaceuticals Ltd. share price forecast

The 10 reports from 4 analysts offering long term price targets for Suven Pharmaceuticals Ltd. have an average target of 541.00. The consensus estimate represents an upside of 12.60% from the last price of 480.45.

- This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced target price.
- This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased target price.
SUVENPHAR
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
SummaryDate Stock Broker Price at Reco.Target Price at reco
Change since reco(%)
Upside(%) TypeReport Discuss
2021-02-15 Suven Pharmaceutical.. +Geojit BNP Paribas
491.10586.00 491.10
(-2.17%)
21.97Buy
2021-02-11 Suven Pharmaceutical.. +ICICI Securities Limited
491.85575.00 491.85
(-2.32%)
19.68Buy
2020-10-31 Suven Pharmaceutical.. +ICICI Securities Limited
 
314.10400.00 314.10
(52.96%)
Target metBuy
2020-10-31 Suven Pharmaceutical.. +Dolat Capital
317.60462.00 317.60
(51.28%)
Target metBuy
2020-10-08 Suven Pharmaceutical.. +ICICI Securities Limited
382.45385.00 382.45
(25.62%)
Target metHold
2020-09-25 Suven Pharmaceutical.. +ICICI Securities Limited
383.70385.00 383.70
(25.22%)
Pre-Bonus/
Split
Hold
2020-08-20 Suven Pharmaceutical.. +Geojit BNP Paribas
 
677.85746.00 677.85
(-29.12%)
Target metAccumulate
2020-08-19 Suven Pharmaceutical.. +ICICI Securities Limited
676.90770.00 676.90
(-29.02%)
Target metBuy
2020-08-18 Suven Pharmaceutical.. +Anand Rathi
678.15760.00 678.15
(-29.15%)
Target metBuy
2020-07-02 Suven Pharmaceutical.. +Geojit BNP Paribas
508.05587.00 508.05
(-5.43%)
Target metBuy